Phaos Technology Holdings (Cayman) (POAS) Receivables (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Receivables came in at $2.9 million in Q4 2025, up 28.77% on a QoQ basis from $2.3 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Receivables (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Receivables data on file, last reported at $2.9 million in Q4 2025.
- Quarterly Receivables changed N/A year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, up 167.75% from the prior year.
- Receivables advanced to $2.9 million in Q4 2025, from $2.3 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $2.9 million in Q4 2025 to a low of $867923.9 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.25 Mn | 4.21 Mn | - | 2.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 2.92 Mn |
| Apr 30, 2025 | 2.27 Mn |
| Apr 30, 2024 | 867,923.93 |